JP Patent
JP6528779B2 — びまん性大細胞型b細胞リンパ腫の予防および/または治療剤
Assigned to Ono Pharmaceutical Co Ltd · Expires 2019-06-12 · 7y expired
What this patent protects
Patent listed against Calquence.
Drugs covered by this patent
- Calquence (ACALABRUTINIB) · AstraZeneca
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.